Securities code: Fujian Cosunter Pharmaceutical Co.Ltd(300436) securities abbreviation: Fujian Cosunter Pharmaceutical Co.Ltd(300436) Announcement No.: 2022046 Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Announcement on holding the online performance explanation meeting of 2021 Annual Report
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as “the company”) will be posted on cninfo.com on April 22, 2022（ http://www.cn.info.com.cn./ ）Disclose the company’s 2021 annual report. In order to facilitate investors to have a deeper understanding of the company’s production, operation and financial situation in 2021, the company will hold an online performance briefing in 2021 from 15:00 to 17:00 on April 29, 2022. The online performance presentation will be held in a remote way, and investors can participate in interactive communication in the following ways. In order to widely listen to the opinions and suggestions of investors and solicit questions from investors in advance, the question channel will be open from the date of issuing the announcement.
Method 1: Search ” Fujian Cosunter Pharmaceutical Co.Ltd(300436) investor relations” in wechat;
Method 2: wechat sweep ” Fujian Cosunter Pharmaceutical Co.Ltd(300436) investor relations”:
The participants in the online performance presentation of this annual report are: Mr. Li Guoping, chairman and general manager of the company, Mr. Li Hongming, chief operating officer, Mr. Ren Hong, independent director, Mr. Lin Xiaohui, director, deputy general manager and Secretary of the board of directors, Mr. Jian Hui, chief financial officer, and Mr. Li Jian, sponsor representative. Investors are welcome to actively participate!
It is hereby announced.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) board of directors April 21, 2022
